Logo image of MS1.DE

MARLEY SPOON GROUP SE (MS1.DE) Stock Fundamental Analysis

FRA:MS1 - Deutsche Boerse Ag - LU2380748603 - Common Stock - Currency: EUR

0.62  0 (0%)

Fundamental Rating

1

Overall MS1 gets a fundamental rating of 1 out of 10. We evaluated MS1 against 52 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of MS1 have multiple concerns. MS1 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MS1 had negative earnings in the past year.
MS1 had a negative operating cash flow in the past year.
MS1.DE Yearly Net Income VS EBIT VS OCF VS FCFMS1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

MS1 has a worse Return On Assets (-88.98%) than 88.46% of its industry peers.
Industry RankSector Rank
ROA -88.98%
ROE N/A
ROIC N/A
ROA(3y)-30.89%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MS1.DE Yearly ROA, ROE, ROICMS1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100 200

1.3 Margins

MS1 has a Gross Margin of 47.63%. This is comparable to the rest of the industry: MS1 outperforms 46.15% of its industry peers.
The Profit Margin and Operating Margin are not available for MS1 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MS1.DE Yearly Profit, Operating, Gross MarginsMS1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

MS1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
MS1 has less shares outstanding than it did 1 year ago.
The debt/assets ratio for MS1 is higher compared to a year ago.
MS1.DE Yearly Shares OutstandingMS1.DE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
MS1.DE Yearly Total Debt VS Total AssetsMS1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

MS1 has an Altman-Z score of 3.47. This indicates that MS1 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MS1 (3.47) is better than 80.77% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 3.47
ROIC/WACCN/A
WACC7.28%
MS1.DE Yearly LT Debt VS Equity VS FCFMS1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -100M -200M

2.3 Liquidity

MS1 has a Current Ratio of 0.51. This is a bad value and indicates that MS1 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.51, MS1 is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
A Quick Ratio of 0.37 indicates that MS1 may have some problems paying its short term obligations.
MS1 has a worse Quick ratio (0.37) than 82.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.37
MS1.DE Yearly Current Assets VS Current LiabilitesMS1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MS1 have decreased strongly by -774.07% in the last year.
MS1 shows a strong growth in Revenue. In the last year, the Revenue has grown by 179.52%.
EPS 1Y (TTM)-774.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.48%
Revenue 1Y (TTM)179.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.63%

3.2 Future

MS1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.33% yearly.
MS1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.53% yearly.
EPS Next Y66.99%
EPS Next 2Y34.85%
EPS Next 3Y24.33%
EPS Next 5YN/A
Revenue Next Year-1.17%
Revenue Next 2Y1.31%
Revenue Next 3Y2.53%
Revenue Next 5YN/A

3.3 Evolution

MS1.DE Yearly Revenue VS EstimatesMS1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 100M 200M 300M
MS1.DE Yearly EPS VS EstimatesMS1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MS1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MS1 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MS1.DE Price Earnings VS Forward Price EarningsMS1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MS1.DE Per share dataMS1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as MS1's earnings are expected to grow with 24.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.85%
EPS Next 3Y24.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MS1!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARLEY SPOON GROUP SE

FRA:MS1 (5/2/2025, 7:00:00 PM)

0.62

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)04-30 2025-04-30
Inst Owners0.36%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.09M
Analysts83.33
Price Target3.34 (438.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)31.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.76
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS17
BVpS-1.26
TBVpS-2.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -88.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.63%
FCFM N/A
ROA(3y)-30.89%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover4.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.37
Altman-Z 3.47
F-Score4
WACC7.28%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-774.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.48%
EPS Next Y66.99%
EPS Next 2Y34.85%
EPS Next 3Y24.33%
EPS Next 5YN/A
Revenue 1Y (TTM)179.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.63%
Revenue Next Year-1.17%
Revenue Next 2Y1.31%
Revenue Next 3Y2.53%
Revenue Next 5YN/A
EBIT growth 1Y-414.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year123.54%
EBIT Next 3Y41.16%
EBIT Next 5YN/A
FCF growth 1Y89.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.81%
OCF growth 3YN/A
OCF growth 5YN/A